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Abstract
Azole antifungal agents are widely used as active ingredients in antifungal pharmaceuticals and agricultural fungicides. An 
increase in the use of azole antifungals has resulted in an increase in the concentration of these compounds in wastewater 
and surface water, with potential implications for agriculture. In the present study, bifonazole (BIF) and clotrimazole (CTZ) 
were selected for investigation because of their widespread use in topical formulations and persistence in the environment. 
The mycoremediation capacity of BIF and CTZ by mycelia of Lentinula edodes in in vitro culture was evaluated. The main 
aim of this study was to identify the presumable biodegradation products of the investigated active pharmaceutical substances 
using the LC/MS/MS method. For this purpose, the media were enriched with the following active pharmaceutical ingredients 
selected for this study: BIF powder, CTZ powder, and BIF cream, each of them at the same concentration of 0.1 mg/mL. 
Subsequently, thin-layer chromatography coupled with densitometry was used to evaluate the content of BIF and CTZ in 
mycelium from in vitro cultures of L. edodes. The degradation process was found to affect primarily the imidazole moiety of 
both investigated compounds. In addition, the amounts of undegraded investigated compounds were found to be 4.98, 9.26, 
and 4.56 mg/g dry weight for BIF powder, CTZ powder, and BIF cream, respectively. Therefore, the findings of this study 
revealed that L. edodes could be considered for remediation of pollution caused by azole antifungal agents.
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Introduction
Civilizational development causes increasing environmental 
contaminations with heavy metals and chemical substances, 
e.g., medicines, which pose a threat to the health and safety 
of humans and animals. Furthermore, the commonly used 
active pharmaceutical ingredients (APIs) and their degrada-
tion products ending up in the environment are currently 
a global problem. The elimination of pollutants can be 
achieved, inter alia, by remediation through fungi; this pro-
cess is known as “mycoremediation”, which is used as a 
biological tool because of its ability to degrade a wide vari-
ety of environmental pollutants, e.g., APIs, and bind with 
toxic heavy metals present in the environment (Kulshreshtha 
et al. 2014; Dąbrowska et al. 2018; Kryczyk et al. 2017a). 
Mycoremediation is a branch of biotechnology that focuses 
mainly on the assessment of biodegradation capacity of 
different species of mushrooms and enhancement of their 
detoxification activity. Because of its desirable characteris-
tics such as high uptake capacity, efficiency, low cost, and 
safety, mycoremediation is currently becoming an increas-
ingly popular method for eliminating pollutants (Kulshresh-
tha et al. 2014). However, further efforts are needed to bet-
ter understand the mechanism underlying the metabolic 
and enzymatic degradation of the drugs by mushrooms to 
increase the efficiency of mycoremediation process.
An increase in the consumption of medicines, mainly 
over-the-counter drugs, is associated with an increase in the 
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risk to the environment. After administration, drugs undergo 
absorption, metabolism, and excretion into the environment 
as unchanged drugs and/or their metabolites. Contamination 
with drugs and their metabolites is also related to their pro-
duction process and not necessarily to the effective methods 
of disposal of unused or out-of-date preparations (Larsson 
2014; Mudgal et al. 2013). APIs and their metabolites (both 
biologically active and inactive) may additionally undergo 
chemical and physical degradation to produce products of 
unknown structure and activity; thus, pollution due to such 
agents becomes difficult to control (Muszyńska et al. 2018; 
Kryczyk et al. 2016).
Antifungal drugs deserve special attention because of 
their persistence and potential negative impact on the envi-
ronment (Kahle et al. 2008). Many antifungal drugs are cur-
rently used; however, the following groups of drugs play a 
vital role in the modern therapy of fungal infections: azole 
derivatives used orally and in topical treatment, squalene 
epoxidase inhibitors, morpholine derivatives, and polyene 
antifungal drugs. The presence of antifungal drugs such as 
ketoconazole, itraconazole, miconazole, clotrimazole (CTZ), 
and propiconazole in sewage and surface water has been 
reported earlier by many studies (Lindberg et al. 2010; Peng 
et al. 2012; Peschka et al. 2007; Van De Steene and Lam-
bert 2008; Van De Steene et al. 2010; Minguez et al. 2016; 
Huang et al. 2010; Roberts and Thomas 2006). Previous 
studies have revealed that antifungal drugs present in the 
natural environment may pose an ecotoxicological threat, 
especially to aquatic organisms (Casado et al. 2014; Halm-
Lemeille and Gomez 2016; Boxall 2004; Yamagishi et al. 
2017). Clotrimazole is on the List of Chemicals for Priority 
Action of OSPAR Commission, because of its persistence in 
the environment and bioaccumulative and ecotoxicological 
properties (OSPAR Commission 2005). In the Netherlands, 
the maximum permissible concentration has been set for 
CTZ (Mudgal et al. 2013). However, CTZ is not completely 
removed during sewage treatment, which can cause contami-
nation of agricultural soil through municipal biosolids or 
wastewater (Sabourin et al. 2011). In addition, it has ecotoxi-
cological effects at environmentally realistic concentrations 
and affects algal communities at picomolar concentrations 
(Mudgal et al. 2013; Porsbring et al. 2009). One of the most 
frequently described methods for effective elimination of 
contaminations caused by pharmaceutical preparations from 
the environment is photocatalytic degradation. Antifungal 
drugs are subject to photocatalytic degradation in the pres-
ence of  TiO2 and ZnO under UVA radiation, but they are 
resistant to photolysis (Kryczyk et al. 2017b, c; Kryczyk-
Poprawa et al. 2018). However, the available literature lacks 
information on the bioremediation of antifungal drugs. 
Therefore, the main aim of the present study was to evalu-
ate the effectiveness of the use of edible fungus Lentinula 
edodes (Berk). Pegler in remediating the pollution caused by 
the azole antifungal agents. Lentinula edodes was selected 
for investigation because of its effectiveness in the mycore-
mediation of xenobiotics such as cephalosporin antibiotics, 
synthetic testosterone, and 17α-ethynylestradiol (Muszyńska 
et al. 2018; Dąbrowska et al. 2018).
Clotrimazole and bifonazole (BIF) were selected for 
further investigation due to their widespread use in topical 
preparations and persistence in the environment. In addi-
tion, their biodegradation mechanism has not been studied 
comprehensively, and therefore, no information is available 
on their role in mycoremediation process. Furthermore, 
structures of the products formed were identified using the 
UPLC/MS/MS/technique. Quantitative analysis of selected 
medicinal substances was carried out by thin-layer chroma-
tography (TLC) coupled with the densitometry method.
Materials and methods
Reagents
Bifonazole and CTZ were obtained from Sigma-Aldrich 
Corp. (St. Louis, MO, USA). HPLC-grade methanol, ace-
tonitrile, and formic acid (98%) were obtained from JT 
Baker. HPLC-grade dichloromethane was obtained from 
Merck (Darmstadt, Germany).
Malt extract, glucose, casein hydrolyzate, l-asparagine, 
adenine, vitamin  B6, and yeast extract were obtained from 
Sigma-Aldrich Corp. (St. Louis, MO, USA). Chemicals such 
as  KH2PO4,  MgSO4·7H2O,  FeCl3,  MnSO4·H2O,  NH4Cl, 
 CaCl2·6H2O, and  ZnSO4·7H2O were obtained from PPH 
Golpharm (Kraków, Poland). Water (quadruple-distilled) 
with a conductivity of less than 1 µS cm−1 was prepared 
using S2-97A2 distillation apparatus (ChemLand, Stargard 
Szczecin, Poland).
Materials
For the study, commercially available fruiting bodies of L. 
edodes (Berk.) Pegler (mushroom), bought at a supermarket 
in Poland (2016), were used. The taxonomic identification 
was performed with MycoKey 4.1 software (http://www.
mycok ey.com) by an expert Muszyńska. The representative 
samples of the material used for further studies are stored 
at the Department of Pharmaceutical Botany, Jagiellonian 
University Medical College, Kraków, Poland.
Preparation of L. edodes mycelial cultures
The fruiting bodies of L. edodes were used to prepare the 
mycelial culture, within which the obtained mycelium 
formed the material for further investigation. The fragments 
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of the hymenial part of fruiting bodies were selected to pre-
pare the mycelial culture of L. edodes. First, the fragments 
of the mushroom fruiting bodies were mixed with sterile 
redistilled water and transferred to the BD Sabouraud Agar 
with chloramphenicol (under laminar air flow). Then, the 
cultures were incubated in a thermostat (ST500/B/40 Pol-
Eko-Apparatus) at 23 °C ± 2 °C for 2 weeks.
Mycelia derived from the solid medium were used to pre-
pare initial cultures that were cultured on the liquid Oddoux 
medium. The cultures were shaken at a rate of 140 rpm on 
a rotary shaker (ALTEL, Poland) and were incubated at a 
temperature of 23 °C ± 2 °C under 12-h light (900 lx)/12-h 
dark). The cultures of L. edodes were maintained for 2 weeks 
and later subcultured.
Experimental mycelial cultures of L. edodes
For mycoremediation studies, 25 mg of the investigating 
compound (BIF or CTZ) was added into 250 mL of ster-
ile liquid medium inoculated with a mycelial culture of 
L. edodes. To perform mycoremediation tests,  Canespor® 
cream (Bayer) containing 10 mg/g BIF, benzyl alcohol, 
cetostearyl alcohol, cetyl palmitate, 2-octyldodecanol, poly-
sorbate 60, purified water, and sorbitan monostearate were 
used. First, 2.5 g of  Canespor® cream containing 10 mg/g 
BIF was added to 250 mL of sterile liquid medium inocu-
lated with a mycelial culture of L. edodes. Three independ-
ent samples were prepared for each investigated compound. 
Then, the prepared L. edodes mycelial culture was cultivated 
in the same conditions as those for the initial cultures, i.e., 
cultivated on the modified liquid Oddoux medium. After 
14 days of incubation, under these conditions, biomass of L. 
edodes was separated from the medium, mixed with redis-
tilled water, and then freeze-dried using a lyophilizer (Fre-
eZone 4.5, Labconco).
Sample preparation for analysis
Five grams of the powdered mushroom material (mycelium 
from in vitro cultures on media containing CTZ and culture 
media) was extracted with a mixture of methanol and dichlo-
romethane in the ratio of 75:25 (v/v) in an ultrasonic bath 
at 49 kHz for 30 min (Sonic-2, Polsonic). Merged extracts 
(300 mL) were concentrated to dryness using a rotary vac-
uum evaporator at 22 °C ± 2 °C, and the dried extracts were 
then subjected to UPLC/MS/MS analysis.
TLC‑densitometry method
Instruments
The following instruments were used to perform measure-
ments: Densitometer TLC Scanner three controlled by Cats 
4 software and equipped with sample applicator Linomat 
IV (CAMAG, Muttenz, Switzerland); TLC silica gel plates 
of size 20 × 20 cm (Merck, Germany), which were cut to 
a size of 10 × 10 cm; a chromatographic chamber of size 
18 × 9 × 18 cm (Sigma-Aldrich); an analytical balance (WPA 
60/C, Radwag, Poland; with accuracy of 0.1 mg); and a 
microsyringe of 100 μL volume (Hamilton Comp., USA).
Chromatographic analysis
The appropriate portions of pharmaceutical standards of 
BIF and CTZ were dissolved in methanol to obtain standard 
solutions of the following concentrations: BIF, 0.037 mg/
mL and 0.118 mg/mL; CTZ, 0.840 mg/mL and 1.320 mg/
mL. To perform the chromatographic separation process of 
investigated compounds, 5 μl of standard solutions and sim-
ulated mixtures was applied to the chromatographic plates 
(10 × 10 cm) in the form of bands of 8 mm width using 
the sample applicator Linomat. The chromatograms were 
developed using a mobile phase composed of n-hexane:ethyl 
acetate:methanol:water:acetic acid (8.4 + 8 + 3 0.4 + 0.2 v/v) 
to a height of 95 mm, in a chromatographic chamber satu-
rated with the mobile phase for 15 min. Then, chromato-
grams were dried at room temperature, viewed under the 
UV lamp at wavelength of λ = 254 nm, and then subjected to 
densitometry analysis. On the basis of the spectra recorded 
directly from the chromatogram, analytical wavelengths 
were selected for the quantitative analysis. Peaks of inves-
tigated substances in recorded densitograms were found to 
be well separated; their RF values were as follows: ~ 0.62 for 
BIF and ~ 0.65 for CTZ.
Validation of the TLC‑densitometry method
To validate the applied method, specificity, accuracy, preci-
sion, linearity, limit of detection (LOD), and limit of quan-
tification (LOQ) of samples were determined.
Furthermore, accuracy was determined at three concen-
tration levels: 80, 100, and 120%, based on sample analy-
sis of known concentrations and comparison of the results 
obtained by the validated method with true values, followed 
by calculation of the recovery percentage.
In addition, the precision of the applied method was 
determined at three concentrations of substance with respect 
to reference solutions: 50, 100, and 150%. For each concen-
tration, the experiment was performed in triplicate.
The linearity of substances was also determined by com-
paring the relationship between peak area  (mm2) and the 
amount of test substance applied to the plate (μg/spot). A 
series of assays were performed for each substance in the 
following concentration ranges: from 0.037 to 1.406 μg/spot 
for BIF and from 0.840 to 25.200 μg/spot for CTZ.
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The LOD and LOQ were determined from the linearity of 
each substance in the following concentration ranges: from 
0.037 to 0.518 μg/spot for BIF and from 0.840 to 15.200 μg/
spot for CTZ, using the following formula: LOD = 3.3 × Sy/a 
and LOQ = 10 × Sy/a, where Sy denotes estimation error and 
a denotes slope.
UPLC/MS/MS analysis
The UPLC/MS/MS system consisted of a Waters 
 ACQUITY®  UPLC® (Waters Corporation, Milford, MA, 
USA) coupled to a Waters TQD mass spectrometer (elec-
trospray ionization mode ESI-tandem quadrupole). Chro-
matographic separation process was carried out using the 
Acquity UPLC BEH (bridged ethyl hybrid)  C18 column, 
2.1 × 100  mm and 1.7  µm particle size, equipped with 
Acquity UPLC BEH C18 VanGuard pre-column, 2.1 × 5 mm 
and 1.7 µm particle size. The column was maintained at 
40 °C, and eluted under gradient conditions using from 95 
to 0% of eluent A for 10 min, at a flow rate of 0.3 mL min−1. 
Eluent A was composed of water/formic acid (0.1%, v/v), 
and eluent B was composed of acetonitrile/formic acid 
(0.1%, v/v). Chromatograms were recorded using Waters eλ 
PDA detector. Spectra were evaluated in 200–700 nm range 
with 1.2 nm resolution at a sampling rate of 20 points/s. 
Mass spectrometry detection settings of Waters TQD mass 
spectrometer were as follows: source temperature 150 °C, 
desolvation temperature 350 °C, desolvation gas flow rate 
600 L/h, cone gas flow rate 100 L/h, capillary potential 
3.00 kV, and cone potential 30 V for the analysis of BIF 
and 6 V for the analysis of CTZ. Nitrogen was used as both 
nebulizing and drying gas. The data were recorded in the 
scan mode ranging from 50 to 1000 m/z in time intervals of 
0.5 s; eight scans were summed up to obtain the final spec-
trum. The data acquisition software used was MassLynx V 
4.1 (Waters).
Preparation of samples for UPLC/MS/MS analysis
Approximately 200 μL of the sample, after evaporation, was 
diluted in 300 μL of the water with the addition of 1% formic 
acid. The solid-phase extraction cartridges were conditioned 
with 1 mL of methanol, followed by 1 mL of water. The 
investigated samples were applied to the cartridges manually 
and washed with 1 mL of water, followed by the addition 
of 1 mL of methanol–water (50:50, v/v) mixture, and then 
eluted with 1 mL of methanol. The prepared samples were 
injected into the UPLC/MS/MS system for analysis.
Statistical analysis
The results of remediation tests were statistically analyzed 
using the Mann–Whitney U test that allows the comparison 
of differences between two independent groups. One-way 
analysis of variance test with Tukey’s post hoc test of mul-
tiple comparisons was also applied to compare the mean of 
three groups. In both tests, p value < 0.05 was considered 
statistically significant.
Results and discussion
Validation of the TLC‑densitometry method
The results of validation studies are presented in Table 1. 
The proposed method was characterized by high sensitivity; 
LOD for BIF and CTZ was 0.081 and 2.147 μg, respectively. 
LOQ was estimated to be 0.245 and 6.507 μg, respectively. 
The percentage recovery of the investigated compounds 
expressed as mean values for three concentrations was high 
and ranged from 96.59 to 102.02%. The acceptable preci-
sion designated for three concentrations was confirmed by 
the values of variability coefficients RSD, which were in 
the range from 0.33 to 2.11%. Linearity was maintained in 
a wide range: from 0.037 to 1.406 μg/spot for BIF and from 
2.520 to 25.200 μg/spot for CTZ. The result of the statistical 
evaluation of the validated method is presented in Table 2. 
Table 1  Validation of the developed methods with statistical evalua-
tion for TLC-densitometry method
RF retardation factor, x̄ mean value; Sx standard deviation; RSD rel-
ative standard deviation, a the slope of regression line; Sy standard 
error of the estimate, m mass [μg/spot]
Validation parameters Bifonazole Clotrimazole
RF ~ 0.62 ~ 0.65
LOD
[μg/spot]
0.081
a = 11,405.4
Sy = 280.7
2.147
a = 393.5
Sy = 256.2
LOQ
[μg/spot]
0.245 6.507
Recovery
80%
[%]
x̄ = 98.38
Sx = 0.781
RSD = 0.79%
x̄ = 101.10
Sx = 0.340
RSD = 0.33%
Recovery
100%
[%]
x̄ = 102.02
Sx = 0.413
RSD = 0.41%
x̄ = 98.33
Sx = 0.831
RSD = 0.84%
Recovery
120%
[%]
x̄ = 96.59
Sx = 0.468
RSD = 0.49%
x̄ = 97.99
Sx = 0.362
RSD = 0.37%
Precision
50%
c [mg/mL]
x̄ = 0.660
Sx = 0.0063
RSD = 0.95%
x̄ = 1.044
Sx = 0.0063
RSD = 0.60%
Precision
100%
c [mg/mL−1]
x̄ = 1.323
Sx = 0.0086
RSD = 0.65%
x̄ = 2.100
Sx = 0.0444
RSD = 2.11%
Precision
150%
c [mg/mL−1]
x̄ = 1.983
Sx = 0.0078
RSD = 0.39%
x̄ = 3.116
Sx = 0.0204
RSD = 0.66%
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The linearity was assessed by Mandel’s test (p < 0.05 for 
both analyzed substances), the results of which showed 
the validity of the selection of quadratic fit. Linear fit was 
selected for CTZ and square model was selected for BIF. 
Furthermore, Shapiro–Wilk test confirmed normal distribu-
tion of residuals in both cases. The results of Durbin–Watson 
test indicated significant autocorrelation: positive for BIF 
and negative for CTZ. The homogeneity of variance of ran-
dom components in the proposed method was confirmed by 
Bartlett test (p > 0.05).
Identification of degradation products of bifonazole 
and clotrimazole
The identification of the degradation products of BIF and 
CTZ was performed by UPLC/MS analysis. The proposed 
structures of the degradation products of BIF and CTZ are 
shown in Tables 3 and 4, respectively. The degradation pro-
cess was found to affect primarily the imidazole moiety of 
both the investigated compounds, leading to its hydroxy-
lation and conjugation with sugars (BP-5) or uronic acids 
(BP-3, BP-4, BP-6, CP-1, and CP-2). The conjugation of 
primary metabolites of xenobiotics, e.g., polycyclic aromatic 
hydrocarbons with sulfate, glucuronic acid, or glucose, was 
described by previous studies (Cerniglia 1992; Kadri et al. 
2017). Furthermore, the degradation involved opening of 
the imidazole ring (CP-3) and its cleavage (BP-2 and CP-4). 
Hydroxylation of the imidazole ring, which leads to ring 
opening and loss of the imidazole moiety, was reported ear-
lier during the photocatalytic degradation process of CTZ 
(Kryczyk et al. 2017c). The degradation product (2-chlo-
rophenyl) diphenylmethanol (CP-4) was also detected in 
extracts received after laboratory incubation of agricultural 
soils (Sabourin et al. 2011). Previous studies have demon-
strated that fungi are capable of effectively degrading the 
phenols due to the activity of their ligninolytic enzymes and 
indicated the possible degradation process through hydrox-
ylation (Santos and Linardi 2004; Michalowicz and Duda 
2007). Due to the oxidative properties of the ligninolytic 
enzymes produced by L. edodes, the degradation of BIF by 
hydroxylation of the imidazole ring was plausible. CP-4 has 
been previously classified in European Pharmacopoeia as 
impurity A ([2-chlorophenyl]diphenylmethanol) (European 
Pharmacopoeia). Furthermore, the pharmacokinetics studies 
of CTZ following oral administration showed the presence 
of (2-chlorophenyl) diphenylmethanol in urine, serum, and 
bile (Florey 1990). The hydroxylation of phenyl moiety of 
BIF was also observed during the photocatalytic degrada-
tion of this antifungal agent (Kryczyk et al. 2017b). Frag-
mentation of all the observed degradation products involved 
cleavage of the imidazole ring, amidine moiety (CP-3), or 
aminosugar (BP-2), thus yielding carbocations.
Mycoremediation of azole antifungal agents
Figure 1 shows a comparison of mycelium growth in in vitro 
cultures of L. edodes with an addition of BIF, BIF cream, 
and CTZ and without the addition of antifungal drugs (con-
trol). The addition of CTZ and BIF in the form of cream 
caused a slight inhibition of mycelium growth, but the 
resultant mycelium growth did not differ significantly from 
that obtained in initial cultures (not enriched with antifun-
gal drugs selected for the study). However, for mycelium 
enriched with BIF in powder form, most intensive biomass 
growth was observed.
The next stage of the study was comparison of the con-
centrations of the tested substances in L. edodes mycelia 
obtained from in vitro cultures enriched with the investi-
gated antifungal drugs. The concentrations of BIF and CTZ 
in mycelium from L. edodes-extracts on liquid Oddoux 
medium enriched with these substances in the amount of 
25 mg of powder per 250 mL of medium or 2.5 g of BIF 
cream per 250 mL of medium are shown in Fig. 2. There 
were no statistically significant differences (p < 0.05) 
between the concentrations of BIF and CTZ in the extract 
produced from L. edodes mycelium.
The amount of investigated antifungal drugs per gram of 
mycelium dry matter was also compared with control. The 
weight of dry mycelium obtained after 4 weeks of incubation 
was considered for the calculations. The results of analysis 
Table 2   Linear and quadratic equation of examined substances
P - peak surface area  [mm2], m - mass [μg/spot], R2 - coefficient of determination; (p) - p significance
*For quadratic equation
Substance Linear equation (p) Quadratic equation (p) R2 Mandel’s test (p) Shapiro–
Wilk test 
(p)
Durbin–
Watson 
test
Bartlett test (p)
Bifonazole P = 8615.9·m + 1184.9
(0.000) (0.000)
P = − 1547.0·m2 
+10,841.1·m + 682.2
(0.005) (0.000) (0.007)
0.9913* 10.378 (0.0051) 0.940*
(0.906)
0.961* 0.159* (0.991)
Clotrimazole P = 391.1·m + 278.4 
(0.000) (0.036)
P = − 0.2510·m2 +397.8·m + 252.4
(0.834) (0.000) (0.170)
0.9941 0.045 (0.754) 0.957
(0.603)
0.859 0.043 (0.835)
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Table 3  Proposed structures of 
the biodegradation products of 
bifonazole
Compound RT
[min]
[M+H+] Fragmentation 
ions
Structure
BP-1 4.27 327.2 259.1
BP-2 4.38 422.2 243.1
BP-3
BP-4
4.76
4.80
473.2 243.1
BP-5 4.92 443.2 243.1
BP-6 4.99 487.2 243.1
BIF 5.36 311.2 243.1
Note: *[M-H2O]+.
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of BIF and CTZ content in mycelium obtained from in vitro 
cultures of L. edodes on liquid Oddoux medium enriched 
with these substances in the amount of 25 mg of powder per 
250 mL of medium or 2.5 g of BIF cream per 250 mL of 
medium are shown in Fig. 3. The total content of the exam-
ined substances in the mycelia of L. edodes calculated from 
the determined BIF and CTZ content in 1 g of dry matter 
obtained from in vitro cultures of the mycelium dry matter 
was 8.02 and 9.22 mg for BIF and CTZ, respectively, which 
corresponds to 32.1% and 36.9% of the initial quantity of the 
investigated compounds BIF and CTZ, respectively.
Figure 4 shows the results of the determination of BIF 
content in mycelium obtained from in vitro cultures of L. 
edodes on liquid Oddoux medium enriched with this sub-
stance in the amount of 25 mg per 250 mL of medium in the 
form of powder and cream. The use of two different forms 
of the drug allowed demonstrating their effect on the abil-
ity of L. edodes to remediate BIF. Statistically significant 
Table 4  Proposed structures of 
the biodegradation products of 
clotrimazole
Compound RT
[min]
[M+H+] Fragmentation ions Structure
CP-1 4.67 507.1 277.1
CP-2 4.82 521.1 277.1
CP-3 5.03 321.1 277.1
CTZ 5.17 345.1 277.1
CP-4 9.38 277.1* –
Note: *[M-H2O]+.
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differences (p < 0.05) in the content of BIF between differ-
ent forms were observed. Bioaccumulation of BIF occurred 
more efficiently for powder form than for cream form using 
the same dose of active substance—25 mg per 250 mL of 
medium. There were no statistically significant differences 
(p < 0.05) between the content of BIF and CTZ in mycelium 
from in vitro cultures of L. edodes when the powder form of 
both substances was used.
Conclusion
The main purpose of our study was the assessment of the 
ability of L. edodes to accumulate or degrade azole anti-
fungal agents. The selected drug class is widely used as 
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Fig. 1  Comparison of dry matter of Lentinula edodes mycelium 
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edodes cultured on Oddoux 
liquid medium enriched with 
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Fig. 3  BIF and CTZ content in 
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active ingredients in pharmaceuticals, and previous studies 
have shown their presence in sewage and surface water. It 
is worth noting that azole antifungals are used in topical 
formulations and consequently are released unchanged into 
the environment. Because of the application of reproducible 
culture conditions, mycelial in vitro cultures of L. edodes 
allowed for the determination of the degree of bioaccumu-
lation of the examined antifungal drugs. The mean content 
of investigated compounds in mycelium from in vitro cul-
tures of L. edodes was 4.98, 9.26, and 4.56 mg/g dry weight 
for BIF powder, CTZ powder, and BIF cream, respectively. 
Bioaccumulation of BIF occurred more efficiently for pow-
der form than for cream form. The mean total amount of 
BIF accumulated in mycelium from in vitro cultures of L. 
edodes was 9.22 mg and 3.82 mg for BIF powder and BIF 
cream, respectively. It was shown that the ingredients of the 
formulation could affect the availability of the compound for 
mycelium. On the basis of the results obtained, the possibil-
ity of the application of examined species in the process of 
BIF and CTZ remediation was confirmed.
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